September 27, 2024 | Blood Cancer Awareness Month, Patient-centricity
This Blood Cancer Awareness Month, we want to highlight the critical role of patient-centricity in building awareness, understanding, and support for those living with blood cancers.

With over 1.24 million new blood cancer cases diagnosed annually worldwide, the need to ensure patient voices are heard and their experiences acknowledged has never been more vital1.
At Mednet, our work with real blood cancer patients informs every project we undertake within the therapy area. We collaborate with pharmaceutical companies to create campaigns that don’t just raise awareness but also address the day-to-day realities of those affected by blood cancers. Through our proprietary Patient-Centricity Framework, we ensure that these campaigns reflect the unique challenges patients face—from diagnosis to treatment and beyond.
In our experience, patient-centric campaigns lead to more meaningful engagement. Pharma companies that focus on understanding the lived experiences of blood cancer patients are better equipped to deliver messages that resonate, educate, and ultimately, improve outcomes.
What makes a campaign truly impactful? It’s when patients feel heard and understood. The journey of blood cancer patients is complex, often involving emotional, physical, and psychological challenges that extend far beyond the clinical. By placing patients at the heart of awareness campaigns, we help pharma companies:
Blood Cancer Awareness Month is a crucial time for amplifying patient voices. Let’s continue to work together to ensure every campaign is centred on real-world patient needs, bringing their experiences to the forefront.
At Mednet, we believe that patient-centricity isn’t just an approach — it’s the future of healthcare communication. By working with patients directly, we help pharma companies foster deeper connections and build campaigns that truly make a difference in their lives.
Find out more about our Patient Centricity Framework.
1 – Shapira, S., et al. J Pers Med. 2021 27;11(8):724.
This content was provided by Mednet